Connor, Clark & Lunn Investment Management (CC&L)
ADMA icon

Connor, Clark & Lunn Investment Management (CC&L)’s ADMA Biologics ADMA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-66,740
Closed -$1.32M – 1487
2025
Q1 		$1.32M Sell
66,740
-97,146
-59% -$1.68M 0.01% 860
2024
Q4 		$2.81M Sell
163,886
-424,988
-72% -$8M 0.01% 636
2024
Q3 		$11.8M Sell
588,874
-202,917
-26% -$3.16M 0.06% 242
2024
Q2 		$8.85M Buy
791,791
+466,551
+143% +$3.91M 0.04% 300
2024
Q1 		$2.15M Sell
325,240
-69,668
-18% -$381K 0.01% 650
2023
Q4 		$1.78M Sell
394,908
-162,255
-29% -$600K 0.01% 699
2023
Q3 		$1.99M Sell
557,163
-267,487
-32% -$1.03M 0.01% 625
2023
Q2 		$3.04M Buy
824,650
+6,466
+0.8% +$24K 0.02% 498
2023
Q1 		$2.71M Buy
818,184
+3,348
+0.4% +$11.6K 0.01% 492
2022
Q4 		$3.16M Buy
814,836
+649,198
+392% +$2M 0.02% 445
2022
Q3 		$403K Buy
165,638
+134,186
+427% +$322K ﹤0.01% 863
2022
Q2 		$62K Buy
+31,452
New +$61.9K ﹤0.01% 1003

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ADMA Position: Q2 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of ADMA Biologics (ADMA) in Q2 2025, closing a stake of 66,740 shares — an estimated $1.32M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ADMA in Q2 2022 and held it in 12 quarters. The position peaked at $11.8M in Q3 2024. 368 funds tracked by Wall St. Rank hold ADMA as of Q2 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining ADMA Biologics position as of Q2 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 66,740 ADMA Biologics shares in Q2 2025, an estimated $1.32M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ADMA Biologics in Q2 2022 and held it in 12 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ADMA Biologics position peaked at $11.8M in Q3 2024.
  • 368 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2025, filed 7 Aug 2025.